Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.818 USD | -0.41% | -2.34% | -38.36% |
Business Summary
Number of employees: 7
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Tucker
CEO | Chief Executive Officer | 55 | 21-09-15 |
Kevin Coveney
DFI | Director of Finance/CFO | 60 | 23-03-12 |
Jillian Hagel
CTO | Chief Tech/Sci/R&D Officer | 45 | 21-09-15 |
Peter Facchini
PRN | Corporate Officer/Principal | 60 | 21-09-15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Webb
CHM | Chairman | 66 | 22-06-12 |
Joseph Tucker
CEO | Chief Executive Officer | 55 | 21-09-15 |
Frank Pasqualone
BRD | Director/Board Member | 68 | 22-07-12 |
George Kegler
BRD | Director/Board Member | 68 | 20-12-29 |
Director/Board Member | 60 | 20-12-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 7,752,005 | 7,488,852 ( 96.61 %) | 0 | 96.61 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.36% | 5.99M | |
+42.52% | 54.04B | |
+43.57% | 41.96B | |
-1.35% | 41.92B | |
-7.59% | 28.35B | |
+11.69% | 26.35B | |
-22.32% | 19B | |
+7.92% | 13B | |
+28.84% | 12.28B | |
+25.59% | 12.19B |
- Stock Market
- Equities
- ENVB Stock
- Company Enveric Biosciences, Inc.